Penny Nymark

Penny Nymark

Forskningsspecialist
E-postadress: penny.nymark@ki.se
Besöksadress: Nobels väg 13, 17177 Stockholm
Postadress: C6 Institutet för miljömedicin, C6 Ledningskansliet, 171 77 Stockholm
Del av:

Forskningsbeskrivning

  • *Utvalda publikationer:*

    Jeliazkova N, Apostolova MD, Andreoli C, Barone F, Barrick A, Battistelli C,
    Bossa C, Botea-Petcu A, Châtel A, De Angelis I, Dusinska M, El Yamani N,
    Gheorghe D, Giusti A, Gómez-Fernández P, Grafström R, Gromelski M,
    Jacobsen NR, Jeliazkov V, Jensen KA, Kochev N, Kohonen P, Manier N, Mariussen
    E, Mech A, Navas JM, Paskaleva V, Precupas A, Puzyn T, Rasmussen K, Ritchie
    P, Llopis IR, Rundén-Pran E, Sandu R, Shandilya N, Tanasescu S, Haase A,
    *Nymark P.* Towards FAIR nanosafety data. [1]Nat Nanotechnol. 2021 May 20.
    doi: 10.1038/s41565-021-00911-6.

    *Nymark P*, Karlsson HL, Halappanavar S, Vogel U. Adverse Outcome Pathway
    development for assessment of lung carcinogenicity by nanoparticles [2].
    Frontiers in Toxicology, 29 April 2021. doi: 10.3389/ftox.2021.653386

    *Nymark P, * Sachana M, Batista-Leite S, Sund J, Krebs C.E., Sullivan K,
    Edwards S, Viviani L, Willett K, Landesmann B, Wittwehr C. Systematic
    Organization of COVID-19 Data Supported by the Adverse Outcome Pathway
    Framework [3]. Frontiers in Public Health, 19 May 2021, doi:
    10.3389/fpubh.2021.638605

    Halappanavar S, van den Brule S, * Nymark P*, Gaté L, Seidel C, Valentino S,
    Zhernovkov V, Høgh Danielsen P, De Vizcaya A, Wolff H, Stöger T, Boyadziev
    A, Poulsen SS, Sørli JB, Vogel U. Adverse outcome pathways as a tool for the
    design of testing strategies to support the safety assessment of emerging
    advanced materials at the nanoscale. [4] Part Fibre Toxicol. 2020 May
    25
  • 17(1):16. doi: 10.1186/s12989-020-00344-4.

    *Nymark P*, Bakker M, Dekkers S, Franken R, Fransman W, García-Bilbao A,
    Greco D, Gulumian M, Hadrup N, Halappanavar S, Hongisto V, Hougaard KS,
    Jensen KA, Kohonen P, Koivisto AJ, Dal Maso M, Oosterwijk T, Poikkimäki M,
    Rodriguez-Llopis I, Stierum R, Sørli JB, Grafström R. Toward Rigorous
    Materials Production: New Approach Methodologies Have Extensive Potential to
    Improve Current Safety Assessment Practices. [5]Small. 2020
    Feb
  • 16(6):e1904749. doi: 10.1002/smll.201904749. Epub 2020 Jan 8.

    Soeteman-Hernandez LG, Apostolova MD, Bekker C, Dekkers S, Grafström RC,
    Groenewold M, Handzhiyski Y, Herbeck-Engel P, Hoehener K, Karagkiozaki V,
    Kelly S, Kraegeloh A, Logothetidis S, Micheletti C, *Nymark P*, Oomen A,
    Oosterwijk T, Rodríguez-LLopis I, Sabella S, Sanchez Jiménez A, Sips A,
    Suarez-Merino B, Tavernaro I, van Engelen J, Wijnhoven SWP, Noorlander CW.
    Safe innovation approach: Towards an agile system for dealing with
    innovations. [6] Materials Today Communications, Volume 20, 2019, 100548,
    ISSN 2352-4928, doi: 10.1016/j.mtcomm.2019

    Giusti A, Atluri R, Tsekovska R, Gajewicz A, Apostolova MD, Battistelli CL,
    Bleeker EAJ, Bossa C, Bouillard j, Dusinska M, Gómez-Fernández P,
    Grafström R, Gromelski M, Handzhiyski Y, Jacobsen NR, Jantunen P, Jensen KA,
    Mech A, Navas JM, *Nymark P*, Oomen AG, Puzyn T, Rasmussen K, Riebeling C,
    Rodriguez-Llopis I, Sabella S, Riego Sintes J, Suarez-Merino B, Tanasescu S,
    Wallin H, Haase A. Nanomaterial grouping: Existing approaches and future
    recommendations [7]. NanoImpact, Volume 16, 2019, 100182, ISSN 2452-0748,
    doi: 10.1016/j.impact.2019.100182

    *Nymark P*, Kohonen P, Hongisto V, Grafström RC. Toxic and Genomic
    Influences of Inhaled Nanomaterials as a Basis for Predicting Adverse
    Outcome. [8]Ann Am Thorac Soc. 2018 Apr
  • 15(Suppl 2):S91-S97. doi:
    10.1513/AnnalsATS.201706-478MG.

    *Nymark P*, Rieswijk L, Ehrhart F, Jeliazkova N, Tsiliki G, Sarimveis H,
    Evelo CT, Hongisto V, Kohonen P, Willighagen E, Grafström RC. A Data Fusion
    Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions.
    [9]Toxicol Sci. 2018 Mar 1
  • 162(1):264-275. doi: 10.1093/toxsci/kfx252.

    *Nymark P*, Wijshoff P, Cavill R, van Herwijnen M, Coonen ML, Claessen S,
    Catalán J, Norppa H, Kleinjans JC, Briedé JJ. Extensive temporal
    transcriptome and microRNA analyses identify molecular mechanisms underlying
    mitochondrial dysfunction induced by multi-walled carbon nanotubes in human
    lung cells. [10] Nanotoxicology, 2015. 9(5): p. 624-635. doi:
    10.3109/17435390.2015.1017022

    *Nymark P*, Guled M, Borze I, Faisal A, Lahti L, Salmenkivi K, Kettunen E,
    Anttila S, Knuutila S. Integrative Analysis of microRNA, mRNA and aCGH Data
    Reveals Asbestos-Related Changes in Non-Small Cell Lung Cancer. [11] Genes,
    Chromosom. Cancer, 2011. 50(8):585-97. doi: 10.1002/gcc.20880

    *Nymark P*, Wikman H, Hienonen-Kempas T, Anttila S. Molecular and genetic
    changes in asbestos-related lung cancer [12]. Cancer Lett. 2008. 265(1):1-15.
    Doi: 10.1016/j.canlet.2008.02.043

    [1] https://doi.org/10.1038/s41565-021-00911-6
    [2] https://doi.org/10.3389/ftox.2021.653386
    [3] https://doi.org/10.3389/fpubh.2021.638605
    [4] https://pubmed.ncbi.nlm.nih.gov/32450889/
    [5] https://pubmed.ncbi.nlm.nih.gov/31913582/
    [6] https://doi.org/10.1016/j.mtcomm.2019
    [7] https://doi.org/10.1016/j.impact.2019.100182
    [8] https://pubmed.ncbi.nlm.nih.gov/29676641/
    [9] https://pubmed.ncbi.nlm.nih.gov/29149350/
    [10] http://doi.org/10.3109/17435390.2015.1017022
    [11] http://doi.org/10.1002/gcc.20880
    [12] http://doi.org/10.1016/j.canlet.2008.02.043

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI